Identification of protein biomarkers to differentiate between gram-negative and gram-positive infections in adults suspected of sepsisShow others and affiliations
2025 (English)In: BMC Infectious Diseases, E-ISSN 1471-2334, Vol. 25, no 1, article id 1576
Article in journal (Refereed) Published
Abstract [en]
Background: Sepsis is mostly caused by bacterial infections and requires a prompt diagnosis. There is a need for improved diagnostics by differentiating between gram-negative and gram-positive bacterial infections.
Methods: The plasma levels of 285 unique proteins in patients with gram-negative infection (n = 154), gram-positive infection (n = 92), and in healthy controls (n = 35) were quantified using proximity extension assay. Three machine learning algorithms; random forest, recursive feature elimination, and adaptive least absolute shrinkage and selection operator (Lasso) were employed to identify discriminative proteins, with their effectiveness assessed using accuracy metrics. The selected proteins were further evaluated for their ability to differentiate between gram-negative and gram-positive infections through logistic regression and area under the receiver operating characteristic curve.
Results: We identified 55 discriminative proteins differentiating between gram-negative and gram-positive infections using the Lasso, the best performing algorithm. The discriminative proteins achieved AUROC values of 0.69 for gram-negative infections and 0.66 for gram-positive infections, both compared to the remaining groups, and 0.58 for differentiating between the two infection groups. Comparative statistical analysis revealed no significant differences in protein expression between gram-negative and gram-positive patients.
Conclusions: We identified 55 proteins with some discriminative potential between gram-negative and gram-positive infections. However, the overall predictive performance was low and did not exceed that of established single biomarkers. These findings highlight the challenges of applying a multimarker approach in infection classification and emphasize the need for further studies using larger and more diverse cohorts, as well as broader analytical methods, to explore their potential clinical utility.
Clinical trial: Not applicable.
Place, publisher, year, edition, pages
BioMed Central (BMC), 2025. Vol. 25, no 1, article id 1576
Keywords [en]
Biomarkers, Diagnostics, Gram-negative bacteria, Gram-positive bacteria, Machine learning, Proteomics, Sepsis, biological marker, C reactive protein, procalcitonin, adult, algorithm, analytic method, area under the curve, Article, blood sampling, clinical article, cohort analysis, controlled study, diagnostic test accuracy study, enzyme linked immunosorbent assay, Escherichia coli, female, Gram negative sepsis, Gram positive bacterium, Gram positive infection, Haemophilus influenzae, human, Klebsiella pneumoniae infection, learning algorithm, leukocyte count, liquid chromatography-mass spectrometry, major clinical study, male, mass spectrometry, predictive value, principal component analysis, protein expression, Pseudomonas infection, quality control, random forest, retrospective study, sensitivity and specificity, Staphylococcus aureus, Streptococcus agalactiae, urea nitrogen blood level, diagnosis, Gram negative bacterium
National Category
Infectious Medicine Microbiology in the Medical Area
Research subject
Infection Biology
Identifiers
URN: urn:nbn:se:his:diva-26016DOI: 10.1186/s12879-025-11973-5ISI: 001616372100013PubMedID: 41239342Scopus ID: 2-s2.0-105021831664OAI: oai:DiVA.org:his-26016DiVA, id: diva2:2016929
Funder
Knowledge Foundation, BioMine grant no. 206/0330Region Västra GötalandSwedish Research Council, 2021-01008Vinnova, 2020-04141Vinnova, 2020-04733Swedish Agency for Economic and Regional Growth, 20370391Swedish Research Council, 2022-01449Knut and Alice Wallenberg Foundation, 2020.0239
Note
CC BY 4.0
© The Author(s) 2025
Correspondence Address: M. Irani Shemirani; Department of Diagnostics and Interventions, Umeå University, Umeå, Sweden; email: mahnaz.irani-shemirani@umu.se; CODEN: BIDMB
Open access funding provided by University of Gothenburg. This study was supported by research grants from the Swedish Knowledge Foundation (BioMine grant no. 206/0330, http://www.kks.se). AS is funded by Region Västra Götaland; Swedish Research Council [2021-01008 and ]; the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement [1006009]; Sweden's Innovation Agency [2020-04141 and 2020-04733]; The Swedish Agency for Economic and Regional Growth [20370391]. AVM was funded by the Swedish Research Council [2022-01449]; Knut and Alice Wallenberg Foundation [2020.0239].
2025-11-272025-11-272025-12-01Bibliographically approved